Profile
Nicholas Franco is currently a Director at Echo-Sense, Inc. and a Director at Immune Biosolutions, Inc. He previously worked as the SVP-International Commercial Operations at Aptalis Pharma Canada ULC from 2007 to 2011, and as the Chief Business Development Officer & EVP at Actelion Ltd. from 2011 to 2023.
He also held positions as a Principal at Novartis Pharma Schweiz AG and as the Vice President-International Commercial Operations at TA SASU.
Franco received his undergraduate degree and MBA from McGill University.
Nicholas Franco active positions
| Companies | Position | Start |
|---|---|---|
Echo-Sense, Inc. | Director/Board Member | - |
Immune Biosolutions, Inc.
Immune Biosolutions, Inc. BiotechnologyHealth Technology Creates quality antibodies as detection tools, quantification and visualization | Director/Board Member | 26/04/2023 |
Former positions of Nicholas Franco
| Companies | Position | End |
|---|---|---|
| ACTELION | Corporate Officer/Principal | 01/02/2023 |
Aptalis Pharma Canada ULC
Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Corporate Officer/Principal | 01/01/2011 |
TA SASU
TA SASU Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on gastrointestinal diseases and cystic fibrosis | Corporate Officer/Principal | - |
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Researches and develops vaccines for viral diseases | Corporate Officer/Principal | - |
Training of Nicholas Franco
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Aptalis Pharma Canada ULC
Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Actelion Ltd.
Actelion Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets pharmaceutical drugs | Health Technology |
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Researches and develops vaccines for viral diseases | Commercial Services |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TA SASU
TA SASU Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on gastrointestinal diseases and cystic fibrosis | Health Technology |
Echo-Sense, Inc. | |
Immune Biosolutions, Inc.
Immune Biosolutions, Inc. BiotechnologyHealth Technology Creates quality antibodies as detection tools, quantification and visualization | Health Technology |
- Stock Market
- Insiders
- Nicholas Franco
















